Developed the OnPulse(TM) technology platform, a technology which, at its core, has been proven to significantly improve blood flow (both volume and velocity).

Summary

Sky Medical Technology Ltd has developed the OnPulseTM technology platform, which has been proven to significantly improve blood flow (both volume and velocity). The results indicate that the platform can be used across a variety of indications, challenging both pharmaceutical and device solutions on the market today.

The primary initial applications for the technology are:

- Prevention and treatment of Deep Vein Thrombosis (DVT);

- Surgical recovery;

- Chronic wound care (of ‘hard to heal’ wounds); and

- Elite sports recovery.

Product

Technology Growth EIS

Sector

Medical Devices

Status

Closed – Partial Exit

HMRC

Advanced Assurance

Company Website

https://goo.gl/qP6aH2

Other News

Sky Medical Technology Launches New geko™ Website
The geko™ device makes breakthrough in pre-operative oedema reduction
Sky Medical Technology & the South Tees Hospitals NHS Foundation trust win pres…